Priority Pharmaceuticals

Jaipur, India Founded: 2011 • Age: 15 yrs
Manufacturer of tablets, capsules, drops, and injectables

About Priority Pharmaceuticals

Priority Pharmaceuticals is a Healthcare company based in Jaipur (India) founded in 2011 by Abhishek Jain and Sanjay Patni. Manufacturer of tablets, capsules, drops, and injectables. It operates on a Traditional Pharmaceuticals model. Its Indian entity Priority Pharmaceuticals Private Limited reported revenue of β‚Ή7.12 Cr. Priority Pharmaceuticals offers products and services including Priority Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.

Company details

Priority Pharmaceuticals, led by Abhishek Jain as Co-Founder Director, Sanjay Patni as Co-Founder Director, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of tablets, capsules, drops, and injectables. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

Key Metrics
  • Annual Revenue
    ₹7.12 Cr

    FY 2025 · +174% YoY

  • Net Profit
    ₹15.7 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹61.8 Lakh

    FY 2025 · 9% margin

Products & Services of Priority Pharmaceuticals

Priority Pharmaceuticals offers a comprehensive portfolio of products and services, including Priority Pharmaceuticals Platform.

Priority Pharmaceuticals Platform
Healthcare

Manufacturer of tablets, capsules, drops, and injectables

Board of directors of Priority Pharmaceuticals Private Limited (Priority Pharmaceuticals)

Priority Pharmaceuticals Private Limited is the primary company behind Priority Pharmaceuticals. The board of Priority Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Sonakshi Jain, appointed in 2011.

DirectorDesignationAppointedTenureEntity
Sonakshi Jain
DIN 03047076
Director23 May 201115 yrs 5 moPriority Pharmaceuticals Private Limited
Sanjay Kumar Patni
DIN 03531217
Director23 May 201115 yrs 5 moPriority Pharmaceuticals Private Limited
Manju Jain
DIN 03531225
Director23 May 201115 yrs 5 moPriority Pharmaceuticals Private Limited
Abhishek Jain
DIN 03531230
Director23 May 201115 yrs 5 moPriority Pharmaceuticals Private Limited

People of Priority Pharmaceuticals

2 people are tracked at Priority Pharmaceuticals (2 in leadership).

NameRoleGroup
Co-Founder & DirectorLeadership
Co-Founder & DirectorLeadership
Premium access

Complete people profiles for Priority Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Priority Pharmaceuticals

Figures of Priority Pharmaceuticals Private Limited, the primary company behind Priority Pharmaceuticals, for FY 2025. Revenue was ₹7.12 Cr (+174% year on year). Net profit was ₹15.7 Lakh (2% margin). EBITDA was ₹61.8 Lakh (9% margin). Revenue has grown at a compounded annual rate of +63% over three years and +28% over five years.

  • ₹7.12 CrRevenue · FY 2025 · +174% YoY
  • ₹15.7 LakhNet profit · 2% margin
  • ₹61.8 LakhEBITDA · 9% margin
  • ₹11 LakhPaid-up capital
  • +63%Revenue CAGR, 3 years
  • +28%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Priority Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Priority Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Priority Pharmaceuticals

The website of Priority Pharmaceuticals (prioritypharmaceuticals.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 38.7% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Priority Pharmaceuticals

Priority Pharmaceuticals was founded in 2011.

Priority Pharmaceuticals is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.

The primary company behind Priority Pharmaceuticals, Priority Pharmaceuticals Private Limited, reported revenue of β‚Ή7.12 Cr for FY 2025, up 174% year on year.

Priority Pharmaceuticals, led by Abhishek Jain as Co-Founder Director, Sanjay Patni as Co-Founder Director, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of tablets, capsules, drops, and injectables. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

Priority Pharmaceuticals offers Priority Pharmaceuticals Platform.

Priority Pharmaceuticals operates through Priority Pharmaceuticals Private Limited.

The legal entities of Priority Pharmaceuticals currently have 4 directors, including Sonakshi Jain, Sanjay Kumar Patni, Manju Jain and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available